Azithromycin reduces airway inflammation induced by human rhinovirus in lung allograft recipients
- PMID: 30989728
- DOI: 10.1111/resp.13550
Azithromycin reduces airway inflammation induced by human rhinovirus in lung allograft recipients
Abstract
Background and objective: Human rhinovirus (RV) is a common upper and lower respiratory pathogen in lung allograft recipients causing respiratory tract exacerbation and contributing towards allograft dysfunction and long-term lung decline. In this study, we tested the hypothesis that RV could infect both the small and large airways, resulting in significant inflammation.
Methods: Matched large and small airway epithelial cells (AEC) were obtained from five lung allograft recipients. Primary cultures were established, and monolayers were infected with RV1b over time with varying viral titre. Cell viability, receptor expression, viral copy number, apoptotic induction and inflammatory cytokine production were also assessed at each region. Finally, the effect of azithromycin on viral replication, induction of apoptosis and inflammation was investigated.
Results: RV infection caused significant cytotoxicity in both large AEC (LAEC) and small AEC (SAEC), and induced a similar apoptotic response in both regions. There was a significant increase in receptor expression in the LAEC only post viral infection. Viral replication was elevated in both LAEC and SAEC, but was not significantly different. Prophylactic treatment of azithromycin reduced viral replication and dampened the production of inflammatory cytokines post-infection.
Conclusion: Our data illustrate that RV infection is capable of infecting upper and lower AEC, driving cell death and inflammation. Prophylactic treatment with azithromycin was found to mitigate some of the detrimental responses. Findings provide further support for the prophylactic prescription of azithromycin to minimize the impact of RV infection.
Keywords: airway epithelium; cell biology; epithelial cells; infection and inflammation; viral infection.
© 2019 Asian Pacific Society of Respirology.
Comment in
-
Not just the common cold: Rhinovirus infection in lung allograft recipients.Respirology. 2019 Dec;24(12):1134-1135. doi: 10.1111/resp.13571. Epub 2019 Apr 19. Respirology. 2019. PMID: 31004394 No abstract available.
References
REFERENCES
-
- Khalifah A, Hachem R, Chakinala M, Schechtman K. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am. J. Respir. Crit. Care Med. 2004; 170: 181-7.
-
- Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, Wagnetz D, Chaparro C, Singer LG, Keshavjee S. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J. Heart Lung Transplant. 2011; 30: 735-42.
-
- Bridges ND, Spray TL, Collins MH, Bowles NE, Towbin JA. Adenovirus infection in the lung results in graft failure after lung transplantation. J. Thorac. Cardiovasc. Surg. 1998; 116: 617-23.
-
- Billings JL, Hertz MI, Savik K, Wendt CH. Respiratory viruses and chronic rejection in lung transplant recipients. J. Heart Lung Transplant. 2002; 21: 559-66.
-
- Milstone AP, Brumble LM, Barnes J, Estes W, Loyd JE, Pierson RN, Dummer S. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur. Respir. J. 2006; 28: 131-7.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
